Retention of subjects in HIV treatment programmes is crucial for the success of treatment. We evaluated retention/loss to follow-up (LTFU) in subjects receiving established care in Malawi.
Introduction
In resource-limited settings, significant time lapses often occur between enrolment of subjects who are eligible for antiretroviral therapy (ART) in programmes and treatment initiation. Delays in ART initiation impact patient adherence, generate high attrition rates and compromise scaleup initiatives. Specific interventions that increase the retention in care of HIV-infected people are much needed in sub-Saharan Africa. This is particularly true where pregnant women living with HIV/AIDS are concerned. In an era in which World Health Organization (WHO) B and B+ regimens are in place, shortening or eliminating the time between diagnosis and treatment visits is crucial for retention purposes. This can be difficult to achieve, however, in busy clinics where there is a need to confirm a diagnosis, initiate care and establish patient confidence and hope, all in a single visit.
In the Drug Resource Enhancement Against AIDS and Malnutrition (DREAM) programme experience, this can be made possible through the provision of ART in a timely manner to the patient, in association with counselling for adherence, which is provided and monitored by patient advocates, or activists, members of the patient community. Immediate provision of medicines that effectively treat HIV infection reassures patients that their condition is treatable and, in the case of pregnant women, that everything possible is being done to protect their infants from acquiring HIV infection. Other key components for long-term follow-up with engagement and retention in care include patient education and awareness of HIV signs and symptoms. For the purpose of educating patients, support meetings provided through a community network can be made possible at a reasonable cost, and a variety of educational materials, including books and pamphlets published in local dialects, are helpful tools. The establishment of a rapport with community members who perform home visits for patient education and evaluation, and assist patients with prescriptions and intake of medications, is also extremely helpful for retention in care, if patients consent to such contact. While patients are receiving ART, a network of support for adherence is established, and retention in care is significantly facilitated. Although the initial cost of the DREAM model is higher than the average cost of care in Malawi, from a long-term perspective these efforts are sustainable and cost-effective, particularly when one of the main goals is retention of patients in care with low loss to follow-up (LTFU) rates, as detailed in one of our recent analyses [1] .
A particular issue with pregnant women living with HIV/AIDS is that, in many health delivery programmes in sub-Saharan Africa, the experience is that, once maternal ART is stopped because women are no longer breastfeeding, retention in care often becomes a problem. Therefore, the availability of the B+ approach may actually improve adherence and retention in care.
The DREAM programme is a public health programme designed and established by the Community of Sant'Egidio for management of HIV care in 10 countries in subSaharan Africa. The programme incorporates prompt initiation of ART following determination of subject eligibility. As there are so many variables involved in the evaluation of programme performance in terms of measuring adherence and retention in care, in the present analysis, we assessed retention of patients in care at our clinical sites in Malawi through a comparison of multiple parameters potentially associated with LTFU and non-loss to follow-up (non-LTFU) among subjects during the calendar year of 2014. All patients were enrolled in the programme in previous years. Multiple parameters were evaluated for identification of predictors of poor retention.
Methods
The study population consisted of patients registered for Home Care and Community Care at the DREAM centres in Malawi who were prescribed combination ART (cART) prior to 2014. LTFU was assessed during the calendar year of 2014 for all registered patients receiving cART, including children (age 0-15 years). LTFU was defined as > 90 days from the last unattended (or prescribed) event, including medical visit, food or drug receipt, and laboratory visit for blood analysis. Parameters collected included: dates of clinic visits, age, gender, baseline WHO clinical category, CD4 cell count, viral load, body mass index (BMI), haemoglobin values, dates on which antiretrovirals were prescribed, dates on which prescriptions were filled, dates on which treatment was initiated, and retention data, including keeping of appointments (or LTFU). Sociodemographic parameters collected included family composition, existence of household (father/husband or mother/wife), type of dwelling, access to electricity, mode of transportation to clinic, and education.
Standard DREAM treatment guidelines included provision of triple ART to all pregnant women if gestational age was > 25 weeks or if they were at WHO clinical stage 3-4 regardless of CD4 cell count, or continuation of prior ART regimens if the patient was already receiving ART prior to the current pregnancy. For nonpregnant adults, the standard treatment according to the national guidelines was prescribed.
A composite index was generated for the travel time to the centre and means of transportation, termed "distance to health centre". This variable was dichotomized as time > 60 min and use of bus as means of transportation. Two adherence markers were investigated in this patient population: the keeping of clinic visit appointments and pharmacy visits for retrieval of medications. Both parameters are often used as proxies for adherence [2] .
Data were censored as of 31 December 2014. The hypotheses tested in this analysis were as follows: (1) LTFU happens more frequently in the period following the initiation of cART; (2) no significant differences exist in social and cultural characteristics between LTFU and non-LTFU subjects, although low adherence and special stressors and trigger events may lead to loss of retention in care; (3) active monitoring and patient interviews concerning LTFU can, to some extent, impact the frequency of LTFU by reducing its occurrence. 
Results
In 2014, the total number of subjects registered at the Malawi DREAM clinics was 15 099. This included 10 854 nonpregnant adults (age ≥ 15 years), 2501 pregnant women and 1744 children. In that year, 202 subjects were LTFU (1.3%). This was the cumulative number of subjects who started cART at any time before 2014 and were LTFU in 2014. The total number of women in follow-up was 10 732, with 148 being LTFU in 2014 (1.4%), while 4364 men were registered in the programme, with 54 being LTFU (1.2%) (P = 0.27). Only nine (0.5%) of 1744 paediatric patients in care were LTFU as opposed to 1.4% (n = 193) of 13 355 adults (P < 0.01; OR 0.35; 95% CI 0.18-0.69). When subjects were evaluated according to time in care, the mean number of days in care for the 202 LTFU patients was 1338 (SD 671.9) days vs. 1544 (SD 766.7) days for the 14 897 non-LTFU subjects (P < 0.01). Similarly, duration of ART was greater for non-LTFU subjects, with a mean of 1530 days of ART (SD 770.5 days) for the 13 871 subjects for whom duration of ART data were available vs. 1300 days of ART (SD 714) for 202 LTFU subjects (P < 0.01). Despite statistically significant differences, time in care and time on treatment were high in both groups of patients.
Individual clinical and laboratory parameters were associated with LTFU, as shown in Table 1 . Subjects who were LTFU had a higher mean viral load (3.8 log 10 HIV-1 RNA copies/mL) compared with non-LTFU subjects (3.5 log 10 copies/mL; P = 0.02) and a higher mean BMI (22.1 vs. 20.8, respectively; P < 0.01). Baseline CD4 cell count, baseline haemoglobin level, and WHO clinical stage were not significantly different between LTFU and non-LTFU subjects. These findings suggest that LTFU subjects might have appeared to be healthier than non-LTFU subjects, which could have impacted their perception of illness.
LTFU was impacted by centre location (urban vs. rural). The two urban centres of Blantyre and Lilongwe had 178 LTFU episodes (88.1%) of the total of 202. While in the 10 medium to small rural centres LTFU rates were close to 0 in most places, in Blantyre and Lilongwe LTFU rates were 2.8% and 2.1%, respectively, as shown in Table 1 . Urban centres provided care to 6716 subjects, or 44.5% of the study population. In the medium to small rural centres, retention rates were close to 100% (P < 0.01), as shown in Table 2 . Interestingly, the type of dwelling was also associated with LTFU, with individuals living in a Using the bus was a more expensive means of transportation as many patients walked or rode a bicycle. The composite index (which took into account the time it took to reach the centre and means of transportation) was the most powerful predictor in the univariable analysis, with an RR of 3.97 (95% CI 2.84-5.37; P < 0.01). The findings suggested that greater distance and the need to use money for transportation by bus were associated with LTFU, with 50 patients (0.6%) in the lower index (i.e. shorter distance) stratum being LTFU compared with 152 (2.3%) in the higher index stratum. A total of 5325 patients (35%) used public transportation to reach the health centre; of these, 1525 (30%) travelled for < 1 h and 3710 (70%) for ≥ 1 h.
The absence of a maternal figure in the household was significantly associated with LTFU in our patient population (RR 1.57; 95% CI 1.17-2.09; P < 0.01). Although subjects were adults, if the female matriarch was missing from the household, the estimated risk of LTFU increased by 58%.
LTFU was also more prevalent in individuals who had a detectable HIV-1 viral load > 50 copies/mL of plasma at the last clinic appointment (2.3% of these patients). Among virologically suppressed individuals, LTFU was 1%. The RR of LTFU in nonvirologically suppressed individuals was 2.28 (95% CI 1.72-3.01; P < 0.01).
The Pearson's correlation coefficient between keeping regular appointments and not being LTFU subsequently was 0.19 for clinic visits (P < 0.01) and 0.24 (P < 0.01) for regular pharmacy visits.
In order to better delineate factors associated with LTFU in our population, a binary logistic regression analysis was performed (forward stepwise model). The main variables were: urban vs. rural housing status, type of dwelling, HIV-1 viral load at last appointment, education, distance index, and maternal survival status. In the final stage, the model discarded the first two variables. All parameters were dichotomized and coded to demonstrate the respective risk reduction in LTFU. A lower distance index and an undetectable viral load at last appointment were the strongest predictors protecting against LTFU, although low education and mother still alive retained independent protective effects ( Table 3) .
Discussion
Adherence can be defined as the patient's capacity to follow the recommended treatment plan, including taking medications as prescribed, following medical advice including behavioural and dietary guidance, having the necessary laboratory testing performed and consistently coming for scheduled appointments. In summary, it is a measure of the patient's level of accuracy and consistency in responding favorably to the management plan. Not surprisingly, there is a significant correlation between adherence to ART and virological suppression. In our earlier studies, 97% of subjects who demonstrated ≥ 95% adherence to their ART regimens in the first year of treatment achieved viral loads of < 1000 copies/mL over a 12-month period [3] . Retention, in contrast, refers to continuing in care once the programme of care has been initiated. From a practical point of view, it can be defined as keeping follow-up clinic appointments, that is, maintaining engagement in care. Although adherence is an important proxy for retention, there are other complex factors determining whether a patient continues to be retained in care. There are often "triggering events" which can affect retention, including everyday life events which may trigger LTFU, independently from the patient's environment, education, baseline values and even adherence.
In order to develop a retention reinforcement strategy, we evaluated parameters potentially associated with LTFU in a large series of HIV-infected patients seeking care at any of our health care centres in Malawi during the year 2014. Because of the structure of managed care implemented at our centres [4] , LTFU rates were quite low, largely as a consequence of our community agent programme (or activists), most of whom are patients themselves, and who provide support, counselling and encouragement of patients to engage in care [5] [6] [7] . The nutritional supplementation provided to our patients, including all pregnant and lactating women as well as patients with advanced HIV disease, is probably a strong motivator for continuing in care (8) . Our LTFU rate in 2014 was 1.3% (or 202 subjects), which is a very low proportion, demonstrating that successful engagement of patients in care is feasible in resource-limited settings if there is a programme tailored to patient needs. The WHO B+ approach to care, which was pioneered by Malawi in sub-Saharan Africa, has also proved to be cost-effective and successful in enhancing ART use in the HIV-infected patient population [9, 10] . The LTFU rate observed in our programme is markedly lower than that reported for other programmes in the same geographical region [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , albeit that the populations and programmes evaluated were inherently different from our cohort and programme (many were prevention of mother-to-child HIV transmission programmes), as was the methodology in many studies. Nevertheless, even 1% LTFU can be problematic if one takes into account that this reflects an annual loss and that cumulatively this proportion could significantly impact long-term treatment goals, particularly the goal of curbing the epidemic through universal ART, a strategy that has proved successful in several modelling studies, including our own [23] [24] [25] [26] . In our prior analysis, we developed a mathematical model based on our large cohort data [26] . This model highlighted the dramatic impact that a reduction in LTFU can have on the efficiency and economic sustainability of universal ART coverage over a 4-year period.
Our analysis demonstrated that there were important characteristics associated with retention in our patient population, including older age within the adult population, a longer time in established care, and a longer duration of ART. HIV-infected children under 15 years of age were significantly more likely to be retained in care than adults. Women who enrolled for the purpose of prevention of mother-to-child HIV transmission, however, were less likely to remain in care after delivery of their infants, particularly if subsequent follow-up of their babies over the first year of life demonstrated that they were not HIV-infected.
Biological parameters associated with retention in care included a lower HIV-1 viral burden at baseline and a lower BMI at the time of enrolment in the programme. Potentially, patients with a higher viral load at entry may have had a higher chance of death/disappearance, although the difference in means between retained and LTFU patients was only 0.3 log 10 copies/mL, which may not translate into significant clinical differences. Patients with a lower BMI at baseline were probably more symptomatic at the time of entry into the programme, which may have resulted in greater motivation to remain in care.
We found that retention was more of a problem in urban dwellers. Living in an urban setting and in better housing conditions, and having more years of education were associated with less retention in our population, which was what our univariate analysis demonstrated. Although at first this may seem counterintuitive, urban populations have greater social mobility and are more likely to be employed and to travel, and may also be more prone to accidents. They also have more options in terms of medical care and may change providers more easily. These may be triggers of LTFU which may not necessarily correlate with adherence parameters. In our experience, triggering events for LTFU are more frequent in urban populations, which, for cultural, economic and other anthropological reasons, tend to be more mobile than rural populations. One of the main triggering events noted in this group of patients, in our experience, is patients leaving the DREAM clinic area for a new job in another city or even another country. These events are attributable not only to economic mobility but also to social changes, such as changes in marital status, or a switch in care to the private sector. Of interest, the presence of a maternal figure in the household was significantly associated with retention. Many African families are run by women, who provide the familial, social and economic structure within the household. The absence of a maternal figure, even if patients are adult, may mean that there is no one to influence an individual's capacity to seek and continue in care over time.
In addition to the mother in the family being alive and less education being associated with a lower risk of LTFU, our binary logistic regression analysis demonstrated that the most important parameters associated with retention were having a detectable viral load at the last appointment and a lower distance index. Detectable viraemia is often a surrogate for nonadherence, and in this situation adherence to ART appears to be predictive of future LTFU. Living at a distance from the health centre, to the point that public transportation needed to be used, was a significant risk factor for LTFU, probably not only because of the distance, but also because of economic factors.
Our findings are important as we try to develop a retention reinforcement strategy to address the multiple and complex challenges of patient retention in care. Identifying the profile of individuals at risk is highly relevant as it enables development of interventions targeting patients at highest risk of LTFU. Although overall LTFU in our programme is very low, multiple ART programmes may face significant challenges with patient retention, with LTFU rates of 20% or higher in the first year [27, 28] . As treatment for prevention remains the mantra for containing the spread of HIV world-wide, further efforts should be made to develop innovative strategies to identify and motivate individuals at highest risk of disengagement from care.
